PolyPid Ltd is a privately held drug delivery company. The company has developed a new, innovative family of drug carriers, based on a fusion between two known drug delivery systems: Polymers and Lipid-based systems.

Polypid enables long-lasting and controlled release of Active PharmaceuticalIngredients (APIs). The revolutionary, patented platform can be tailored to almost any API – small molecules, peptides, proteins and nucleic acids-based drugs. The formulations can be pre-programmed in order to achieve the desired release rate of the APIs and the optimal duration, which can last up to several months.

Due to its flexibility, this novel technology platform can be utilized to address numerous medical indications in various fields, such as orthopedics, urology, periodontal, anti-cancer and anti-fungal treatments, as well as surgical accessories.